Salim Syed Score: 30
Analyst at
Mizuho Securities
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-4.0%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
50%
10 W / 10 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
43%
6 W / 8 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
14%
2 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
14%
2 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
50%
7 W / 7 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
47%
8 W / 9 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
67%
2 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 |
AMGEN Inc.
AMGN
|
SELL |
$303.00
Est. +14%
|
$350.53 | $334.05 (Low) |
Pending
|
$337.60
+3.7%
|
| Jun 16, 2026 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$96.00
Est. +41%
|
$68.00 | $68.60 |
Pending
|
$66.27
-2.5%
|
| Jun 15, 2026 |
Biogen Inc
BIIB
|
BUY |
$221.00
Est. +10%
|
$200.05 | $200.99 |
Pending
|
$196.58
-1.7%
|
| Jun 02, 2026 |
Enliven Therapeutics Inc
ELVN
|
BUY |
$62.00
Est. +65%
|
$37.51 | $47.36 |
Pending
|
$45.10
+20.2%
|
| Dec 08, 2025 |
Incyte Corp.
INCY
|
BUY |
$121.00
Est. +18%
|
$102.52 | $112.29 |
Pending
|
$98.22
-4.2%
|
| Nov 20, 2025 |
Assembly Biosciences Inc
ASMB
|
BUY |
$40.00
Est. +3%
|
$39.00 | $39.71 |
Bullseye Hit (±1%)
|
$24.44
-37.3%
|
| May 16, 2025 |
Unity Biotechnology Inc
UBX
|
BUY |
$1.00
Est. +22%
|
$0.82 | $1.12 |
Target Met
|
$0.20
-75.6%
|
| Sep 25, 2024 |
Wave Life Sciences Ltd.
WVE
|
BUY |
$19.00
Est. +132%
|
$8.19 | $16.74 |
Miss
|
$6.16
-24.8%
|
| Sep 24, 2024 |
Assembly Biosciences Inc
ASMB
|
BUY |
$36.00
Est. +121%
|
$16.26 | $27.17 |
Miss
|
$24.44
+50.3%
|
| Sep 23, 2024 |
Enliven Therapeutics Inc
ELVN
|
BUY |
$39.00
Est. +64%
|
$23.80 | $30.01 |
Miss
|
$45.10
+89.5%
|
| Sep 10, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$163.00
Est. +41%
|
$115.28 | $121.06 |
Miss
|
$51.44
-55.4%
|
| Sep 03, 2024 |
BridgeBio Pharma Inc
BBIO
|
BUY |
$53.00
Est. +77%
|
$29.92 | $52.85 |
Bullseye Hit (±1%)
|
$66.27
+121.5%
|
| Sep 03, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$113.00
Est. +2%
|
$111.09 | $121.06 |
Target Met
|
$51.44
-53.7%
|
| Aug 16, 2024 |
Atara Biotherapeutics Inc
ATRA
|
BUY |
$18.00
Est. +164%
|
$6.83 | $18.71 |
Target Met
|
$10.07
+47.4%
|
| Jun 17, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$90.00
Est. +39%
|
$64.52 | $119.69 |
Target Met
|
$123.76
+91.8%
|
| May 09, 2024 |
AMGEN Inc.
AMGN
|
SELL |
$235.00
Est. +24%
|
$307.31 | $257.05 (Low) |
Miss
|
$337.60
-9.9%
|
| Apr 09, 2024 |
Enliven Therapeutics Inc
ELVN
|
BUY |
$34.00
Est. +86%
|
$18.30 | $30.01 |
Miss
|
$45.10
+146.4%
|
| Apr 05, 2024 |
Cytokinetics Inc
CYTK
|
BUY |
$99.00
Est. +36%
|
$72.74 | $61.37 |
Miss
|
$78.78
+8.3%
|
| Mar 22, 2024 |
Nkarta Inc
NKTX
|
BUY |
$25.00
Est. +180%
|
$8.92 | $8.23 |
Miss
|
$2.86
-67.9%
|
| Sep 28, 2022 |
Biogen Inc
BIIB
|
BUY |
$270.00
Est. +37%
|
$197.79 | - | - |
$196.58
-0.6%
|
| May 10, 2022 |
AMGEN Inc.
AMGN
|
SELL |
$208.00
Est. +13%
|
$239.24 | - | - |
$337.60
-41.1%
|
| Feb 08, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$75.00
Est. +18%
|
$63.70 | - | - |
$123.76
+94.3%
|
| Feb 07, 2022 |
Biogen Inc
BIIB
|
SELL |
$207.00
Est. +6%
|
$221.30 | - | - |
$196.58
+11.2%
|
AMGEN Inc.
AMGN
Jun 16, 2026
Signal & Target
SELL
$303.00
Start Price
$350.53
Best Price (1Y)
$334.05
Current Price
$337.60
Return
+3.7%
BridgeBio Pharma Inc
BBIO
Jun 16, 2026
Signal & Target
BUY
$96.00
Start Price
$68.00
Best Price (1Y)
$68.60
Current Price
$66.27
Return
-2.5%
Biogen Inc
BIIB
Jun 15, 2026
Signal & Target
BUY
$221.00
Start Price
$200.05
Best Price (1Y)
$200.99
Current Price
$196.58
Return
-1.7%
Enliven Therapeutics Inc
ELVN
Jun 02, 2026
Signal & Target
BUY
$62.00
Start Price
$37.51
Best Price (1Y)
$47.36
Current Price
$45.10
Return
+20.2%
Incyte Corp.
INCY
Dec 08, 2025
Signal & Target
BUY
$121.00
Start Price
$102.52
Best Price (1Y)
$112.29
Current Price
$98.22
Return
-4.2%
Assembly Biosciences Inc
ASMB
Nov 20, 2025
Signal & Target
BUY
$40.00
Start Price
$39.00
Best Price (1Y)
$39.71
Current Price
$24.44
Return
-37.3%
Unity Biotechnology Inc
UBX
May 16, 2025
Signal & Target
BUY
$1.00
Start Price
$0.82
Best Price (1Y)
$1.12
Current Price
$0.20
Return
-75.6%
Wave Life Sciences Ltd.
WVE
Sep 25, 2024
Signal & Target
BUY
$19.00
Start Price
$8.19
Best Price (1Y)
$16.74
Current Price
$6.16
Return
-24.8%
Assembly Biosciences Inc
ASMB
Sep 24, 2024
Signal & Target
BUY
$36.00
Start Price
$16.26
Best Price (1Y)
$27.17
Current Price
$24.44
Return
+50.3%
Enliven Therapeutics Inc
ELVN
Sep 23, 2024
Signal & Target
BUY
$39.00
Start Price
$23.80
Best Price (1Y)
$30.01
Current Price
$45.10
Return
+89.5%
Vaxcyte Inc
PCVX
Sep 10, 2024
Signal & Target
BUY
$163.00
Start Price
$115.28
Best Price (1Y)
$121.06
Current Price
$51.44
Return
-55.4%
BridgeBio Pharma Inc
BBIO
Sep 03, 2024
Signal & Target
BUY
$53.00
Start Price
$29.92
Best Price (1Y)
$52.85
Current Price
$66.27
Return
+121.5%
Vaxcyte Inc
PCVX
Sep 03, 2024
Signal & Target
BUY
$113.00
Start Price
$111.09
Best Price (1Y)
$121.06
Current Price
$51.44
Return
-53.7%
Atara Biotherapeutics Inc
ATRA
Aug 16, 2024
Signal & Target
BUY
$18.00
Start Price
$6.83
Best Price (1Y)
$18.71
Current Price
$10.07
Return
+47.4%
Gilead Sciences, Inc.
GILD
Jun 17, 2024
Signal & Target
BUY
$90.00
Start Price
$64.52
Best Price (1Y)
$119.69
Current Price
$123.76
Return
+91.8%
AMGEN Inc.
AMGN
May 09, 2024
Signal & Target
SELL
$235.00
Start Price
$307.31
Best Price (1Y)
$257.05
Current Price
$337.60
Return
-9.9%
Enliven Therapeutics Inc
ELVN
Apr 09, 2024
Signal & Target
BUY
$34.00
Start Price
$18.30
Best Price (1Y)
$30.01
Current Price
$45.10
Return
+146.4%
Cytokinetics Inc
CYTK
Apr 05, 2024
Signal & Target
BUY
$99.00
Start Price
$72.74
Best Price (1Y)
$61.37
Current Price
$78.78
Return
+8.3%
Nkarta Inc
NKTX
Mar 22, 2024
Signal & Target
BUY
$25.00
Start Price
$8.92
Best Price (1Y)
$8.23
Current Price
$2.86
Return
-67.9%
Biogen Inc
BIIB
Sep 28, 2022
Signal & Target
BUY
$270.00
Start Price
$197.79
Best Price (1Y)
-
Current Price
$196.58
Return
-0.6%
AMGEN Inc.
AMGN
May 10, 2022
Signal & Target
SELL
$208.00
Start Price
$239.24
Best Price (1Y)
-
Current Price
$337.60
Return
-41.1%
Gilead Sciences, Inc.
GILD
Feb 08, 2022
Signal & Target
BUY
$75.00
Start Price
$63.70
Best Price (1Y)
-
Current Price
$123.76
Return
+94.3%
Biogen Inc
BIIB
Feb 07, 2022
Signal & Target
SELL
$207.00
Start Price
$221.30
Best Price (1Y)
-
Current Price
$196.58
Return
+11.2%